PENNSYLVANIA SOCIETY OF ONCOLOGY AND HEMATOLOGY

EIN: 222464542

MECHANICSBURG, PA

Total Revenue
$313,392
Total Expenses
$125,379
Total Assets
$928,331
Net Assets
$863,365
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Principal Officer
STEVEN J COHEN MD
Phone
8337701553
Tax Period
2025-01-01 to 2025-12-31

PENNSYLVANIA SOCIETY OF ONCOLOGY AND HEMATOLOGY is a small nonprofit that reported $313K in total revenue in fiscal year 2025. Revenue surged 26% from the prior year, signaling strong growth momentum. The organization ran a surplus of $188K, a strong 60% operating margin.

Mission

THE PENNSYLVANIA SOCIETY OF ONCOLOGY AND HEMATOLOGY IS AN ORGANIZATION OF PHYSICIANS AND HEALTH CARE PROFESSIONALS DEDICATED TO ADVANCING QUALITY HEMATOLOGIC AND ONCOLOGIC CARE THROUGH EDUCATION, ADVOCACY, NETWORKING, AND LEADERSHIP.

Program Service Accomplishments

Program 1

IN 2025, THE ANNUAL MEETING WAS HELD IN A NEW LOCATION (CENTRAL PENNSYLVANIA) AND ON A WEEKEND RATHER THAN WEEKDAY. THE CONFERENCE PROVIDED 5.25 HOURS OF CME CREDIT AND ATTRACTED A TOTAL OF 61...

Read more

IN 2025, THE ANNUAL MEETING WAS HELD IN A NEW LOCATION (CENTRAL PENNSYLVANIA) AND ON A WEEKEND RATHER THAN WEEKDAY. THE CONFERENCE PROVIDED 5.25 HOURS OF CME CREDIT AND ATTRACTED A TOTAL OF 61 ATTENDEES, DOWN 10 FROM THE PRIOR YEAR. TEN EDUCATIONAL PROGRAMS ON VARIOUS ONCOLOGY AND HEMATOLOGY TOPICS WERE PRESENTED BY EXPERTS IN THEIR FIELD, AND ONE NON-CME PRODUCT SHOWCASE WAS ALSO PRESENTED. OUR CALL FOR POSTERS DREW 21 SUBMISSIONS, THREE OF WHICH WERE CHOSEN FOR ORAL PRESENTATION. A NEW INITIATIVE PROVIDED A 300 TRAVEL STIPEND TO SUPPORT ONCOLOGY/HEMATOLOGY FELLOWS IN TRAINING TO ATTEND THE 2025 ANNUAL MEETING. PARTICIPANTS WERE REQUIRED TO: BE ENROLLED IN AN ONCOLOGY/HEMATOLOGY FELLOWSHIP PROGRAM IN PENNSYLVANIA; BECOME MEMBERS OF PSOH WHICH IS FREE FOR THE DURATION OF THEIR TRAINING; ATTEND THE ENTIRE MEETING; AND COMPLETE A POST MEETING SURVEY. TEN STIPENDS WERE OFFERED. THE MEETING ENJOYED STRONG SUPPORT FROM INDUSTRY, ATTRACTING 50 COMPANIES, AN INCREASE OF EIGHT OVER 2024, AND AN INCREASED NUMBER OF MEDICAL SCIENCE LIAISONS (MSLS). ADVOCACY, ALWAYS IN THE FOREFRONT FOR PSOH, FOCUSED ON THE PATIENT CENTERED ISSUES OF DRUG SHORTAGES, COPAY ACCUMULATORS/MAXIMIZERS/ALTERNATIVE FUNDING PROGRAMS, PRIOR AUTHORIZATION, 340B, AND REIMBURSEMENT ISSUES FOR PHYSICIANS.

Program 2

PSOH PROVIDES ADVOCACY FOR PATIENT CARE ISSUES AND ROUTINELY DISTRIBUTES INFORMATION REGARDING NEW TREATMENT PROCESSES, DIAGNOSIS AND CARE-RELATED MATERIALS TO PHYSICIANS, HEALTHCARE PROVIDERS AND...

Read more

PSOH PROVIDES ADVOCACY FOR PATIENT CARE ISSUES AND ROUTINELY DISTRIBUTES INFORMATION REGARDING NEW TREATMENT PROCESSES, DIAGNOSIS AND CARE-RELATED MATERIALS TO PHYSICIANS, HEALTHCARE PROVIDERS AND PROFESSIONALS. THE PSOH WEBSITE PROVIDES A RESOURCE FOR MEMBERS TO INTERACT WITH EACH OTHER ON ISSUES RELATED TO THEIR FIELD AND CONNECTS MEMBERS WITH THE NATIONAL ORGANIZATION, ASCO.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0
Program Service Revenue $286,240
Investment Income $27,027
Other Revenue $125
TOTAL REVENUE $313,392

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $9,150
Other Expenses $125,379
TOTAL EXPENSES $125,379

Year-over-Year Comparison

2025 2024 Change
Revenue $313,392 $249,707 +0.3%
Expenses $125,379 $113,531 +0.1%
Net Income $188,013 $136,176 +0.4%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
13
Independent Members
13
Employees
N/A
Volunteers
15

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$0
Total Directors
13
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
SRAMILA AITHAL PRESIDENT-EL 2.00
Officer Director
$0 $0 $0
LAURA FERRINGER BOARD MEMBER 1.00
Director
$0 $0 $0
ADAM BRUFSKY MD BOARD MEMBER 0.50
Director
$0 $0 $0
CRYSTAL S DELINGER MD BOARD MEMBER 1.50
Director
$0 $0 $0
JOHN LEIGHTON JR MD BOARD MEMBER 2.00
Director
$0 $0 $0
KIT LU MD SEC'Y/TREASU 2.00
Officer Director
$0 $0 $0
MOSHE C CHASKY MD IMMED. PAST 1.50
Officer Director
$0 $0 $0
MUHAMMAD RIZVI MD BOARD MEMBER 1.50
Director
$0 $0 $0
NAMARATA VIJAYVERGIA MD BOARD MEMBER 0.20
Director
$0 $0 $0
RENE ROTHSTEIN-RUBIN MD BOARD MEMBER 1.50
Director
$0 $0 $0
SATISH SHAH MD BOARD MEMBER 1.50
Director
$0 $0 $0
STEVEN J COHEN MD PRESIDENT 2.00
Officer Director
$0 $0 $0
CHARU AGGARWAL MD MPH BOARD MEMBER 0.30
Director
$0 $0 $0
E MARIE QUEEN EXECUTIVE DI 17.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $313,392 $125,379 $928,331 $188,013
2024 $249,707 $113,531 $700,924 $136,176
2023 $220,807 $105,098 $545,603 $115,709
Explore More Nonprofits
Top 100 Nonprofits in Pennsylvania Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare PENNSYLVANIA SOCIETY OF ONCOLOGY AND HEMATOLOGY with other nonprofits in Pennsylvania and across the country.